# Armenia Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Armenia HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Armenia (ARM) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $4.9M - Products: 21 - Buyer markets: 25 - Average CAGR: +34.0% - Global sector size: $442.7B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $297.5B | $1.7M | $112.6B | -1.4% | 22 | +0.0% | | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.8B | $4.4K | $11.7B | +148.0% | 2 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $23.5B | $208.5K | $9.8B | +51.6% | 7 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $17.7B | $9.6K | $8.7B | +27.8% | 3 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $18.5B | $12.4K | $7.8B | +0.0% | 7 | +0.0% | | HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $11.9B | $2.3K | $7.4B | -13.2% | 2 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $11.7B | $1.8M | $7.0B | +44.0% | 4 | +0.1% | | HS 330300 - Perfumes and toilet waters | $11.0B | $64.3K | $6.2B | +31.1% | 5 | +0.0% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $15.9B | $871.0K | $5.4B | +385.4% | 3 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $5.5B | $26.5K | $3.1B | -7.3% | 4 | +0.0% | | HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $0.3 | $2.0B | -94.7% | 1 | +0.0% | | HS 284690 - Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $1.6K | $1.5B | +10.4% | 1 | +0.0% | | HS 281820 - Aluminium oxide: other than artificial corundum | $2.3B | $10.1K | $1.1B | +16.9% | 1 | +0.0% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $2.7B | $2.0K | $1.1B | +48.1% | 2 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $1.4B | $462.5 | $1.0B | +100.5% | 2 | +0.0% | | HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $723.6M | $230.2 | $674.9M | +41.7% | 1 | +0.0% | | HS 340600 - Candles, tapers and the like | $1.0B | $143.9K | $640.7M | +61.0% | 1 | +0.0% | | HS 293379 - Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $1.3B | $6.9K | $627.6M | +23.7% | 1 | +0.0% | | HS 293090 - Organo-sulphur compounds: n.e.s. in heading no. 2930 | $639.9M | $82.0 | $532.1M | +1.4% | 1 | +0.0% | | HS 293134 - Organo-inorganic compounds: organo-phosphorus derivatives, sodium-3-(hydroxysilyl)propyl methylphosphonate | $323.1M | $4.6K | $522.7M | +20.7% | 1 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.0B | $15.6 | $510.2M | -72.2% | 1 | +0.0% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $44.4B calculated opportunity across 10 products. - Switzerland, Liechtenstein (CHE): $30.7B calculated opportunity across 2 products. - Germany (DEU): $22.4B calculated opportunity across 11 products. - China (CHN): $13.1B calculated opportunity across 5 products. - Slovenia (SVN): $9.7B calculated opportunity across 1 products. - Belgium (BEL): $9.0B calculated opportunity across 4 products. - United Kingdom (GBR): $7.9B calculated opportunity across 5 products. - Spain (ESP): $7.7B calculated opportunity across 4 products. - Netherlands (NLD): $7.1B calculated opportunity across 4 products. - Japan (JPN): $5.9B calculated opportunity across 4 products. - Canada (CAN): $5.7B calculated opportunity across 3 products. - Russia (RUS): $5.2B calculated opportunity across 4 products. ## Growth stars - HS 300215: +385.4% average CAGR, $5.4B calculated opportunity. - HS 293359: +148.0% average CAGR, $11.7B calculated opportunity. - HS 330210: +100.5% average CAGR, $1.0B calculated opportunity. - HS 340600: +61.0% average CAGR, $640.7M calculated opportunity. - HS 330499: +51.6% average CAGR, $9.8B calculated opportunity. - HS 300439: +48.1% average CAGR, $1.1B calculated opportunity. - HS 382499: +44.0% average CAGR, $7.0B calculated opportunity. - HS 293299: +41.7% average CAGR, $674.9M calculated opportunity. - HS 330300: +31.1% average CAGR, $6.2B calculated opportunity. - HS 300212: +27.8% average CAGR, $8.7B calculated opportunity. ## Diversification opportunities - HS 300490: 22 buyer markets, $112.6B calculated opportunity. - HS 330499: 7 buyer markets, $9.8B calculated opportunity. - HS 382200: 7 buyer markets, $7.8B calculated opportunity. - HS 330300: 5 buyer markets, $6.2B calculated opportunity. - HS 382499: 4 buyer markets, $7.0B calculated opportunity. - HS 300290: 4 buyer markets, $3.1B calculated opportunity. - HS 300212: 3 buyer markets, $8.7B calculated opportunity. - HS 300215: 3 buyer markets, $5.4B calculated opportunity. - HS 293359: 2 buyer markets, $11.7B calculated opportunity. - HS 293499: 2 buyer markets, $7.4B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.